Filter Results:
(990)
Show Results For
- All HBS Web
(990)
- People (4)
- News (256)
- Research (615)
- Events (9)
- Multimedia (24)
- Faculty Publications (396)
Show Results For
- All HBS Web
(990)
- People (4)
- News (256)
- Research (615)
- Events (9)
- Multimedia (24)
- Faculty Publications (396)
- 24 May 2011
- First Look
First Look: May 24
decade. The small venture that he had started with a few of his scientist colleagues in the late 1990s to discover novel medicine in a research-driven organisation had grown into one of Europe's largest biotech firms by revenues. Their success was mainly founded on... View Details
Keywords: Sean Silverthorne
- 31 May 2016
- First Look
May 31, 2016
significant investment in bio-similars as a way to differentiate itself from its generic drug industry peers, has to negotiate with its parent company and the innovative pharma division on how best to commercialize its bio-similar... View Details
Keywords: Sean Silverthorne
- 14 May 2020
- Research & Ideas
What Leaders Can Do to Fight the COVID Fog
dedicated sleep space—no working from bed. Caffeine, alcohol, and other drugs can degrade sleep quality. Exercise In addition to its physical benefits, aerobic exercise notably improves clarity of thought and helps regulate negative... View Details
Keywords: by Boris Groysberg and Robin Abrahams
- 12 Oct 2006
- First Look
First Look: October 12, 2006
risky investments under profound uncertainty and long time horizons for R&D; how to learn rapidly enough to keep pace with advances in drug science knowledge; and how to integrate capabilities across a broad spectrum of scientific and... View Details
Keywords: Sean Silverthorne
- 28 Aug 2017
- Research & Ideas
Should Industry Competitors Cooperate More to Solve World Problems?
example here. More business leaders in the health care sector recognize that industry actors that engage in egregious pricing of drugs bring all kinds of problems to the whole industry. Silverthorne: You note that companies by themselves... View Details
- 25 Feb 2020
- News
Alumni and Faculty Books for March 2020
solve our nation's drug epidemic. These accounts, illustrated with searing images by the award-winning photographer Lynsey Addario, provide a picture of working-class families needlessly but profoundly damaged as a result of decades of... View Details
- Profile
Kanwaljit Bakshi
her dual law and business degrees to fight some of the world's most disturbing criminals. Since 2011, Brochu, 42, has been the United Nations Office on Drugs and Crime's Expert on Child Exploitation and Human Trafficking, a position she... View Details
Keywords: Nonprofit / Government
- 02 Jan 2020
- Op-Ed
Medicare for All or Public Option: Can Either Heal Health Care?
for All published by the Harvard Business Review. [Image: Hispanolistic] Related Reading Germany May Have the Answer for Reducing Drug Prices What Hospitals Must Learn to Compete Making Health Insurance That Consumers Actually Like What... View Details
- 01 Jun 2003
- News
Ruling from the Bench
notorious criminals. Presiding over complex, multidefendant trials at the height of the 1980s crack cocaine epidemic, Snyder stared down members of the “Wild Cowboys” drug gang like Daniel (“Fat Danny”) Rincon and Stanley (“Trigger”)... View Details
- 09 Mar 2020
- Research & Ideas
Warring Algorithms Could Be Driving Up Consumer Prices
being in second place, it’s a pretty good place to be.” Consumers end up paying more To study how pricing algorithms affect competition, MacKay and Brown collected detailed pricing data from five large, multicategory retailers selling the same over-the-counter allergy... View Details
- 01 Jun 2008
- News
A Binary Formula
career in drug development and biotech companies, leading both R&D and business functions. She teaches the MBA elective Inventing Breakthroughs and Commercializing Science and an Executive Education offering Leading Science-Based... View Details
- 27 Feb 2018
- First Look
First Look at New Research and Ideas, February 27, 2018
company. Purchase this case: https://cb.hbsp.harvard.edu/cbmp/product/718403-PDF-ENG Harvard Business School Case 618-033 BeiGene BeiGene was a biopharmaceutical company founded on exploiting a temporal regulatory policy discontinuity. Because of regulatory challenges... View Details
Keywords: Sean Silverthorne
- 16 Oct 2013
- Op-Ed
Response to Readers: Combating Climate Change with Nuclear Power and Fracking
With more than 7,500 views and 180-plus tweets, I want to thank everyone for taking the time to read the original HBS Working Knowledge piece, The Case for Combating Climate Change with Nuclear Power and Fracking, and, in particular, for sharing your thoughts with one... View Details
- 19 Aug 2024
- News
Quantum Leap
like realistically modeling molecules for more efficient drug discovery and material design. The equipment that SEEQC—short for Scalable Energy Efficient Quantum Computing—and pronounced “seek”—is using to achieve this computational dream... View Details
- 03 Oct 2006
- First Look
First Look: October 3, 2006
considering selling its royalty interest in Enbrel, Amgen's blockbuster drug for the treatment of rheumatoid arthritis. In assessing whether to sell, and at what price, the hospital must determine its value to a potential buyer as well as... View Details
Keywords: Sean Silverthorne
- 23 Oct 2018
- News
Coming of Age as the World Comes Apart
sort of drug addiction, my mother who suffered from mental illness had started to disappear. And I guess, if I was a psychologist, I'd say, I, at 11, decided that I would be perfect in everything that I could control. I remember when my... View Details
- 11 Oct 2006
- Research & Ideas
The Success of Reverse Leveraged Buyouts
business press and savvy business experts such Warren Buffett. It didn’t help when one of the most publicized RLBOs—Refco—collapsed in 2005 shortly after its initial public offering. And on September 21, a 70-million share offering for View Details
- 27 Jan 2003
- Research & Ideas
New Cluster Mapping Project Helps Companies Locate Facilities
A: There is some heartening progress. The word is out among retailers about the under-served market in inner cities. Drug chains, such as Walgreen's, and many other retailers, such as Home Depot, are pursuing this opportunity to good... View Details
Keywords: by Sean Silverthorne
- 01 Sep 2010
- News
Letters to the Editor
Wells states, “I would hesitate to have those kinds of financial dealings thought of as equivalent to the problems of drug money, or terrorist financing, or secreted money from blatant bribes.” Maybe so. But the ethics of tax cheats are... View Details
- 28 May 2014
- Research & Ideas
Building Histories of Emerging Economies One Interview at a Time
you are saving lives. So it has to have a humanitarian angle to it." (Cipla manufactures generic versions of a number of commonly prescribed medicines and is the world's largest manufacturer of the antiretroviral drugs that fight HIV and... View Details
Keywords: by Julia Hanna